Your browser doesn't support javascript.
loading
Procedural success in transaxillary transcatheter aortic valve implantation according to type of transcatheter heart valve: results from the multicenter TAXI registry.
Schaefer, Andreas; Bhadra, Oliver D; Conradi, Lenard; Westermann, Dirk; Kellner, Caroline; De Backer, Ole; Bajoras, Vilhelmas; Sondergaard, Lars; Qureshi, Waqas T; Kakouros, Nikolaos; Aldrugh, Summer; Amat-Santos, Ignacio; Kaneko, Tsuyoshi; Harloff, Morgan; Teles, Rui; Nolasco, Tiago; Neves, Jose Pedro; Abecasis, Miguel; Werner, Nikos; Lauterbach, Michael; Sacha, Jerzy; Krawczyk, Krzysztof; Trani, Carlo; Romagnoli, Enrico; Mangieri, Antonio; Condello, Francesco; Regueiro, Ander; Brugaletta, Salvatore; Biancari, Fausto; Niemelä, Matti; Giannini, Francesco; Toselli, Marco; Ruggiero, Rossella; Buono, Andrea; Maffeo, Diego; Bruno, Francesco; Conrotto, Federico; D'Ascenzo, Fabrizio; Savontaus, Mikko; Pykäri, Jouni; Ielasi, Alfonso; Tespili, Maurizio; Cimmino, Michele; Albanese, Michele; Biondi-Zoccai, Giuseppe; Corcione, Nicola; Morello, Alberto; Giordano, Arturo.
Afiliação
  • Schaefer A; Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Martinistraße 52, 20246, Hamburg, Germany. and.schaefer@uke.de.
  • Bhadra OD; Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Martinistraße 52, 20246, Hamburg, Germany.
  • Conradi L; Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, Martinistraße 52, 20246, Hamburg, Germany.
  • Westermann D; Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
  • Kellner C; Department of Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany.
  • De Backer O; The Heart Center-Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Bajoras V; The Heart Center-Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Sondergaard L; Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Qureshi WT; Department of Interventional Cardiology, Division of Cardiology and Vascular Diseases, Vilnius University, Hospital Santaros Clinics, Vilnius, Lithuania.
  • Kakouros N; The Heart Center-Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Aldrugh S; Division of Cardiology, University of Massachusetts School of Medicine, Worcester, MA, USA.
  • Amat-Santos I; Division of Cardiology, University of Massachusetts School of Medicine, Worcester, MA, USA.
  • Kaneko T; Division of Cardiology, University of Massachusetts School of Medicine, Worcester, MA, USA.
  • Harloff M; Cardiology Department, CIBERCV, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.
  • Teles R; Division of Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Nolasco T; Division of Cardiac Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Neves JP; Cardiothoracic Surgery Department, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
  • Abecasis M; Cardiothoracic Surgery Department, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
  • Werner N; Cardiothoracic Surgery Department, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
  • Lauterbach M; Cardiothoracic Surgery Department, Hospital de Santa Cruz, Carnaxide, Lisbon, Portugal.
  • Sacha J; Department of Medicine 3, Barmherzige Brüder Hospital, Trier, Germany.
  • Krawczyk K; Department of Medicine 3, Barmherzige Brüder Hospital, Trier, Germany.
  • Trani C; Department of Cardiology, Institute of Medical Sciences, University Hospital, University of Opole, Opole, Poland.
  • Romagnoli E; Department of Cardiology, Institute of Medical Sciences, University Hospital, University of Opole, Opole, Poland.
  • Mangieri A; Institute of Cardiology, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
  • Condello F; Institute of Cardiology, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.
  • Regueiro A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Brugaletta S; Cardio Center, Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy.
  • Biancari F; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Niemelä M; Cardio Center, Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy.
  • Giannini F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Cardiovascular Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Toselli M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Cardiovascular Institute, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Ruggiero R; Clinica Montevergine, GVM Care & Research, Mercogliano, Italy.
  • Buono A; Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
  • Maffeo D; Department of Internal Medicine, Oulu University Hospital, Oulu, Finland.
  • Bruno F; Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy.
  • Conrotto F; Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy.
  • D'Ascenzo F; Interventional Cardiology Unit, GVM Care and Research Maria Cecilia Hospital, Cotignola, Italy.
  • Savontaus M; Interventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Institute, Brescia, Italy.
  • Pykäri J; Interventional Cardiology Unit, Cardiovascular Department, Fondazione Poliambulanza Institute, Brescia, Italy.
  • Ielasi A; Department of Medical Science, Division of Cardiology, Città Della Salute e della Scienza, Turin, Italy.
  • Tespili M; Department of Medical Science, Division of Cardiology, Città Della Salute e della Scienza, Turin, Italy.
  • Cimmino M; Department of Medical Science, Division of Cardiology, Città Della Salute e della Scienza, Turin, Italy.
  • Albanese M; Heart Center, Turku University Hospital, University of Turku, Turku, Finland.
  • Biondi-Zoccai G; Heart Center, Turku University Hospital, University of Turku, Turku, Finland.
  • Corcione N; IRCCS Ospedale Galeazzi Sant'Ambrogio, Milan, Italy.
  • Morello A; Clinical and Interventional Cardiology Unit, Istituto Clinico Sant'Ambrogio, Gruppo Ospedaliero San Donato, Milan, Italy.
  • Giordano A; Interventional Cardiology Unit, Santa Lucia Clinic, S. Giuseppe Vesuviano, Naples, Italy.
Clin Res Cardiol ; 113(1): 48-57, 2024 Jan.
Article em En | MEDLINE | ID: mdl-37138103
ABSTRACT

BACKGROUND:

Transaxillary (TAx) transcatheter aortic valve implantation (TAVI) is a preferred alternative access in patients ineligible for transfemoral TAVI.

AIMS:

This study used the Trans-AXillary Intervention (TAXI) registry to compare procedural success according to different types of transcatheter heart valves (THV).

METHODS:

For the TAXI registry anonymized data of patients treated with TAx-TAVI were collected from 18 centers. Acute procedural, early and 1-month clinical outcomes were adjudicated in accordance with standardized VARC-3 definitions.

RESULTS:

From 432 patients, 368 patients (85.3%, SE group) received self-expanding (SE) THV and 64 patients (14.8%, BE group) received balloon-expandable (BE) THV. Imaging revealed lower axillary artery diameters in the SE group (max/min diameter in mm 8.4/6.6 vs 9.4/6.8 mm; p < 0.001/p = 0.04) but a higher proportion of axillary tortuosity in BE group (62/368, 23.6% vs 26/64, 42.6%; p = 0.004) with steeper aorta-left ventricle (LV) inflow (55° vs 51°; p = 0.002) and left ventricular outflow tract (LVOT)-LV inflow angles (40.0° vs 24.5°; 0.002). TAx-TAVI was more often conducted by right sided axillary artery in the BE group (33/368, 9.0% vs 17/64, 26.6%; p < 0.001). Device success was higher in the SE group (317/368, 86.1% vs 44/64, 68.8%, p = 0.0015). In logistic regression analysis, BE THV were a risk factor for vascular complications and axillary stent implantation.

CONCLUSIONS:

Both, SE and BE THV can be safely used in TAx-TAVI. However, SE THV were more often used and were associated with a higher rate of device success. While SE THV were associated with lower rates of vascular complications, BE THV were more often used in cases with challenging anatomical circumstances.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Substituição da Valva Aórtica Transcateter Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Res Cardiol Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Estenose da Valva Aórtica / Próteses Valvulares Cardíacas / Substituição da Valva Aórtica Transcateter Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Res Cardiol Ano de publicação: 2024 Tipo de documento: Article